|

Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome

RECRUITINGSponsored by Centro Cardiopatici Toscani
Actively Recruiting
SponsorCentro Cardiopatici Toscani
Started2016-12-01
Est. completion2025-12-01
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04087200

Summary

Registration of all ACS patients (STEMI and NSTEMI) admitted to the cardiology ward and scheduled for early invasive strategy. The aim is to evaluate the protective effects of early (on admission) high-dose high-potency statin therapy on early and mid-term cardiac and renal events in this subset of patients.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Acute coronary syndrome (ST elevation and non ST elevation)
* Early invasive strategy

Exclusion Criteria:

* contraindication to statin therapy
* refusal of consent

Conditions2

Acute Coronary SyndromeHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.